[go: up one dir, main page]

AR013735A1 - Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos. - Google Patents

Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos.

Info

Publication number
AR013735A1
AR013735A1 ARP980105429A ARP980105429A AR013735A1 AR 013735 A1 AR013735 A1 AR 013735A1 AR P980105429 A ARP980105429 A AR P980105429A AR P980105429 A ARP980105429 A AR P980105429A AR 013735 A1 AR013735 A1 AR 013735A1
Authority
AR
Argentina
Prior art keywords
antibodies
propeptide
iii
terminal
procolagen
Prior art date
Application number
ARP980105429A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of AR013735A1 publication Critical patent/AR013735A1/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Inmunoensayo para el propéptido del procolágeno III C-terminal que comprende anticuerpos que se unen específicamente a la proteína en una muestrade fluido humano, así como la generacion del PIIICP recombinante y las construccionesp or delecíon para la generacion de los anticuerpos anteriormentemencionados; anticuerpos que se unen específicamente a la regíon I del PIIICP, el propéptido del procolágeno III C-terminal y uso de dichos anticuerpos parala determinacion de lasconcen traciones de PIIICP.
ARP980105429A 1997-10-31 1998-10-29 Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos. AR013735A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97119018A EP0913692A1 (en) 1997-10-31 1997-10-31 An immunoassay for procollagen-III-C-terminal propeptide

Publications (1)

Publication Number Publication Date
AR013735A1 true AR013735A1 (es) 2001-01-10

Family

ID=8227544

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105429A AR013735A1 (es) 1997-10-31 1998-10-29 Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos.

Country Status (5)

Country Link
EP (1) EP0913692A1 (es)
AR (1) AR013735A1 (es)
AU (1) AU2150899A (es)
WO (1) WO1999024835A2 (es)
ZA (1) ZA989925B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053870A1 (de) * 2000-10-31 2002-05-08 Burchardt Elmar Reinhold Procollagen (III)-Propeptide und verwandte Substanzen zur Behandlung von fibrotischen Erkrankungen
DE10149360A1 (de) * 2001-10-06 2003-04-24 Burchardt Elmar Reinhold Verfahren zur immunhistologischen Darstellung von Fibrogenese in histologischen Gewebeschnitten unter Verwendung von Antikörpern gegen humanes C-terminales Procollagen alpha1 (III) Propeptid
US9359633B2 (en) * 2007-11-05 2016-06-07 Nordic Bioscience A/S Biochemical markers for CVD risk assessment
US9404932B2 (en) 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
EP3578664B1 (en) 2009-03-30 2024-10-30 Nordic Bioscience A/S Collagen iv neo-epitope fibrosis assay
CN106053826A (zh) * 2016-05-12 2016-10-26 威海威高生物科技有限公司 Ⅲ型前胶原n端肽定量测定试剂盒及其制备方法
CN109060779A (zh) * 2018-08-09 2018-12-21 苏州长光华医生物医学工程有限公司 适用于化学发光免疫分析仪的温度远程监控系统及方法
US20240003906A1 (en) * 2020-04-16 2024-01-04 Nordic Bioscience A/S Biomarker of Fibrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653450B1 (en) * 1993-01-28 2003-11-25 Cohesion Technologies, Inc. Mutated recombinant collagens
WO1997008311A1 (en) * 1995-08-31 1997-03-06 The Victoria University Of Manchester Novel procollagens
JP2712018B2 (ja) * 1996-05-20 1998-02-10 寳酒造株式会社 モノクローナル抗体

Also Published As

Publication number Publication date
WO1999024835A2 (en) 1999-05-20
WO1999024835A3 (en) 1999-07-22
ZA989925B (en) 1999-05-13
AU2150899A (en) 1999-05-31
EP0913692A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
BR112022013756A2 (pt) Anticorpos anti-trem2 e métodos de uso dos mesmos
ES2128362T3 (es) Fragmentos de proteinas de prion.
DK0871702T3 (da) Cytokin betegnet Lerk-7
ES2187200T3 (es) Proteina hibrida para inhibir la desgranulacion de mastocitos y su uso.
CR8231A (es) Anticuerpos rg1 y uso de los mismos
CL2016002624A1 (es) Anticuerpos humanos que se unen al gen 3 de activación linfocitaria (lag-3) y los usos de estos (divisional sol. n°0308-2011)
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
CL2011000010A1 (es) Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende.
CO6220978A2 (es) Anticuerpos dirigidos a proteina-1 quimio-tactica de monocitos (mcp-1)y sus usos
ECSP034490A (es) Anticuerpos para la il-1b humana
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ES2051897T3 (es) Genes clonados que codifican proteinas de fusion ig-cd4 y su uso.
BR0111731A (pt) Ensaio de combinação de anticorpo/antìgeno do hcv
BRPI9912227B8 (pt) método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método.
BR0208603A (pt) Marcadores de tumor para carcinoma de células renais
CO6280567A2 (es) Establecimiento de un anticuerpo monoclonal para detector de proteinas pag en la circulacion
BR9509172A (pt) Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica
AR013735A1 (es) Inmunoensayo para el propeptido del procolageno iii c terminal, anticuerpos , propeptido del procolageno iii c terminal y uso de los anticuerpos.
AR029642A1 (es) Una molecula de adn aislada que codifica un ligando denominado fhm que pertenece a la familia de supergenes de ligandos de tnf, polipeptidos de fhm, anticuerpos que conjugan fhm, materiales que integran dicha molecula y metodos de uso de dichas moleculas, metodos y compuestos farmaceuticos, metodos
ES2136598T3 (es) Inmunoanalisis de deteccion de anticuerpos monoclonales contra los peptidos de activacion de protrombina y sus productos de degradacion.
PE20010046A1 (es) Anticuerpos anti-idiotipicos recombinantes
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ES2042461T3 (es) Producto y procedimiento para el teñido oxidativo del cabello.
ES2100960T3 (es) Estructura proteica de la toxina vegetal gelonina.
DK1173766T3 (da) Isoform af tenascin-C som markör for neoplasier

Legal Events

Date Code Title Description
FB Suspension of granting procedure